Mid-day market update: Nasdaq rises over 50 points, Washington prime group shares plunge
|Midway through trading Monday, the Dow traded down 0.65% to 34,255.66 while the NASDAQ rose 0.41% to 14,126.79. The S&P also fell, dropping 0.23% to 4,237.53.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,462,280 cases with around 599,760 deaths. India confirmed a total of at least 29,510,410 cases and 374,300 deaths, while Brazil reported over 17,412,760 COVID-19 cases with 487,400 deaths. In total, there were at least 176,001,660 cases of COVID-19 worldwide with more than 3,805,010 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Information technology shares climbed 0.5% on Monday. Meanwhile, top gainers in the sector included Canaan Inc. CAN 21.56%, up 26%, and Bit Digital, Inc. BTBT 20.16%, up 27%.
In trading on Monday, materials shares fell 1.3%.
Top Headline
Accenture PLC ACN 0.6% agreed to acquire Aachen, Germany's engineering consulting and services firm, umlaut.
The financial terms of the transaction remain undisclosed
Equities Trading UP
Enochian Biosciences, Inc. ENOB 105.44% shares shot up 107% to $9.11. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request for a potential functional cure or treatment of HIV.
Shares of RAPT Therapeutics, Inc. RAPT 112.17% got a boost, shooting 115% to $39.95 as the company announced topline results from its Phase 1b trial of RPT193 as monotherapy for moderate-to-severe atopic dermatitis (AD).
iTeos Therapeutics, Inc. ITOS 37.39% shares were also up, gaining 39% to $27.78. iTeos Therapeutics and GlaxoSmithKline plc have agreed to co-develop and co-commercialize EOS-448, an anti-TIGIT monoclonal antibody.
Equities Trading DOWN
Washington Prime Group Inc. WPG 30.06% shares tumbled 24% to $3.67 after the company filed for Chapter 11 bankruptcy.
Shares of Avenue Therapeutics, Inc. ATXI 30.17% were down 33% to $2.8272 after the company received a second Complete Response Letter from the FDA regarding its marketing application seeking approval for IV tramadol.
Inhibikase Therapeutics, Inc. IKT 18.06% was down, falling 22% to $4.66. Inhibikase Therapeutics filed for offering of up to 8 million shares of common stock.
Commodities
In commodity news, oil traded up 0.8% to $71.47, while gold traded down 0.7% to $1,865.80.
Silver traded down 0.3% Monday to $28.075 while copper fell 0.1% to $4.5310.
Euro zone
European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.18%, the Spanish Ibex Index rose 0.83% and the German DAX 30 fell 0.13%. Meanwhile, the London’s FTSE 100 gained 0.18%, French CAC 40 climbed 0.24% and Italy’s FTSE MIB rose 0.16%.
Eurozone industrial production increased 0.8% in April versus a revised 0.4% rise in the previous month.
Economics
There are no major economic released for Monday.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.